Arkolith/Insider Trading/VERA/Form 4

Fordyce Marshall

PRESIDENT AND CEO, DirectorVera Therapeutics, Inc. (VERA) · full profile →Form 4 · filed Jun 24, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$702K
Net Open-Market Flow
-$702K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 23, 2026Sell(S)18K$37.93$698K198K
Jun 23, 2026Sell(S)88$38.43$3K198K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001859453-26-000008) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML